Recently, selective inhibition of nuclear export by the second-generation exportin-1 (XPO1) inhibitor KPT-8602 (eltanexor) was shown to induce apoptosis in various cancer types, including ALL [19, 20], without deleterious effects to normal hematopoiesis [21]. Here, XPO1 is linked to cancer.